Education
About Us
Working with TipRanks
Follow Us
Cibus (CBUS)
NASDAQ:CBUS
Earnings Data
Report Date
Aug 07, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.66Last Year’s EPS
-1.14Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: 20.00%
|Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in regulatory milestones and commercial strategy validation, particularly in gene editing and sustainable ingredients. However, financial results showed increased net loss and SG&A expenses, raising concerns about cash burn and profitability.Company Guidance
During the Cibus, Inc. 2025 Q1 earnings call, the company provided guidance emphasizing its commercial strategy and regulatory advancements. Cibus reported cash and cash equivalents of $23.6 million as of March 31, 2025, with revenue for the first quarter at $1 million, up from $545,000 in the previous year. The net loss was $49.4 million, primarily due to a $21 million non-cash goodwill impairment. Despite this, the company focused on reducing its cash burn rate, targeting a net burn of around $4 million per quarter. Cibus highlighted advancements in its RTDS technology, achieving milestones in rice and canola trait development, and noted significant regulatory progress in Europe and Latin America. The company anticipates nominal revenues from its sustainable ingredients program later in 2025, reflecting its ongoing efforts to optimize operations and maximize shareholder value.Commercial Strategy Validation
Cibus, Inc. demonstrated clear validation of its commercial strategy and the transformative potential of its RTDS technology platform, attracting significant commercial interest across rice, canola, and soybean platforms.
Regulatory Milestones
Historic regulatory milestones achieved, including the California Rice Commission's approval for gene-edited rice trials and favorable USDA APHIS designation for canola disease resistance traits.
Sustainable Ingredients Program Progress
Advanced bio-based fermentation bio fragrance products with successful first stage scale-up, anticipating commercialization agreements with consumer packaged goods partners later this year.
Significant Financial Backing
Cibus, Inc. received $21.4 million net proceeds from a registered direct offering in January 2025, with existing cash sufficient to fund planned operating expenses into the third quarter of 2025.
---
CBUS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CBUS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $2.35 | $2.14 | -8.94% |
Mar 20, 2025 | $2.19 | $2.05 | -6.39% |
Nov 07, 2024 | $4.40 | $5.28 | +20.00% |
Aug 08, 2024 | $7.46 | $7.02 | -5.90% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Cibus (CBUS) report earnings?
Cibus (CBUS) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
What is Cibus (CBUS) earnings time?
Cibus (CBUS) earnings time is at Aug 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CBUS EPS forecast?
CBUS EPS forecast for the fiscal quarter 2025 (Q2) is -0.66.
---